Gadolinium‐based contrast agents: A comprehensive risk assessment
Volume: 46, Issue: 2, Pages: 338 - 353
Published: Jan 13, 2017
Abstract
Gadolinium‐based contrast agents (GBCAs) have been used in magnetic resonance imaging (MRI) since the 1980s and are now administered in up to 35% of all MRI examinations. While GBCAs were initially felt to carry minimal risk, the subsequent identification of GBCAs as the key etiologic factor in the development of nephrogenic systemic fibrosis (NSF) has raised concerns about the broader health impacts of gadolinium exposure. Clinicians,...
Paper Details
Title
Gadolinium‐based contrast agents: A comprehensive risk assessment
Published Date
Jan 13, 2017
Volume
46
Issue
2
Pages
338 - 353
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History